Emergence of TR46/Y121F/T289A in an aspergillus fumigatus isolate from a Chinese patient

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 11, 2015, Pages 7148-7150

  Chen, Yong ^a   Wang, Huan ^b   Lu, Zhongyi ^a   Li, Peng ^a   Zhang, Qing ^a   Jia, Tianye ^b   Zhao, Jingya ^a   Tian, Shuguang ^a   Han, Xuelin ^a   Chen, Fangyan ^a   Zhang, Changjian ^a   Jia, Xiaodong ^a   Huang, Liuyu ^a   Qu, Fen ^b   Han, Li ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; MICONAZOLE; VORICONAZOLE; PYRROLE DERIVATIVE;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; CASE REPORT; CHINESE; DYSPNEA; GENE MUTATION; HUMAN; LEG EDEMA; LUNG ASPERGILLOSIS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE AGED; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; ANTIFUNGAL RESISTANCE; ASPERGILLOSIS; FATALITY; GENETICS; GROWTH, DEVELOPMENT AND AGING; PATHOGENICITY;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; AZOLES; DRUG RESISTANCE, FUNGAL; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED;

EID: 84946200651     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00887-15     Document Type: Article

References (15)

1. Vermeulen E, Lagrou K, Verweij PE 2013. Azole resistance in Aspergillus fumigatus: a growing public health concern. Curr Opin Infect Dis 26:493-500. http://dx.doi.org/10.1097/QCO.0000000000000005.
2. Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, Mellado E, Donders AR, Melchers WJ, Verweij PE. 2008. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 5:e219. http://dx.doi.org/10.1371/journal.pmed.0050219.
3. Lockhart SR, Frade JP, Etienne K.A., Pfaller MA, Diekema DJ, Balajee SA. 2011. Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene. Antimicrob Agents Chemother 55:4465-4468. http://dx.doi.org/10.1128/AAC.00185-11.
4. van der Linden JW, Camps SM, Kampinga G.A., Arends JP, Debets-Ossenkopp YJ, Haas PJ, Rijnders B.J., Kuijper EJ, van Tiel FH, Varga J, Karawajczyk A, Zoll J, Melchers WJ, Verweij PE. 2013. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles. Clin Infect Dis 57:513-520. http://dx.doi.org/10.1093/cid/cit320.
5. Chowdhary A, Sharma C, van den Boom M, Yntema JB, Hagen F, Verweij PE, Meis JF. 2014. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania. J Antimicrob Chemother 69:2979-2983. http://dx.doi.org/10.1093/jac/dku259.
6. Steinmann J, Hamprecht A, Vehreschild M.J., Cornely OA, Buchheidt D, Spiess B, Koldehoff M., Buer J, Meis JF, Rath PM 2015. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany. J Antimicrob Chemother 70:1522-1526. http://dx.doi.org/10.1093/jac/dku566.
7. Chowdhary A, Kathuria S, Xu J., Meis JF. 2013. Emergence of azoleresistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog 9:e1003633. http://dx.doi.org/10.1371/journal.ppat.1003633.
8. Espinel-Ingroff A. 2006. Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B. J Clin Microbiol 44:3616-3622. http://dx.doi.org/10.1128/JCM.01187-06.
9. Balajee SA, Gribskov JL, Hanley E, Nickle D., Marr KA. 2005. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell 4:625-632. http://dx.doi.org/10.1128/EC.4.3.625-632.2005.
10. Chen J, Li H, Li R., Bu D, Wan Z. 2005. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother 55:31-37.
11. Espinel-Ingroff A., Cuenca-Estrella M, Fothergill A., Fuller J, Ghannoum M, Johnson E., Pelaez T, Pfaller MA, Turnidge J. 2011. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob Agents Chemother 55:5150-5154. http://dx.doi.org/10.1128/AAC.00686-11.
12. Espinel-Ingroff A., Diekema DJ, Fothergill A, Johnson E., Pelaez T, Pfaller MA, Rinaldi M.G., Canton E., Turnidge J. 2010. Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). J Clin Microbiol 48:3251-3257. http://dx.doi.org/10.1128/JCM.00536-10.
13. Camps SM, van der Linden JW, Li Y, Kuijper EJ, van Dissel JT, Verweij PE, Melchers WJ. 2012. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrob Agents Chemother 56:10-16. http://dx.doi.org/10.1128/AAC.05088-11.
14. Vermeulen E, Maertens J, Schoemans H., Lagrou K. 2012. Azoleresistant Aspergillus fumigatus due to TR46/Y121F/T289A mutation emerging in Belgium, July 2012. Euro Surveill 17:20326. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20326.
15. Astvad KM, Jensen RH, Hassan T.M., Mathiasen EG, Thomsen GM, Pedersen UG, Christensen M, Hilberg O., Arendrup MC. 2014. First detection of TR46/Y121F/T289A and of TR34/L98H in azole naive patients in Denmark despite negative findings in the environment. Antimicrob Agents Chemother 58:5096-5101. http://dx.doi.org/10.1128/AAC.02855-14.